Report Store | Pharma intelligence
  • My Account
    • 0Shopping Cart
  • $0.00
  • Disease analysis
    • Anemias
    • Bacterial infections
    • Bleeding disorders
    • Brain Cancer
    • Breast and gynecological cancer
    • Cardiovascular and Metabolic
    • Central Nervous System
    • Cerebrovascular diseases
    • Dermatology
    • Diabetes and diabetic complications
    • Gastroenterology
    • Gastrointestinal cancer
    • Head and Neck Cancer
    • Hypertension
    • Immunology and Inflammation
    • Infectious Diseases
    • Ischemic heart disease
    • Leukemia
    • Lung Cancer
    • Lymphoma
    • Oncology overview
    • Market Spotlight
    • Mens Health
    • Neurology
    • Oncology
    • Ophthalmology
    • Other Hematological Cancers
    • Other metabolic diseases
    • Other Solid Cancers
    • Pain
    • Psychiatry
    • Respiratory
    • Rheumatology
    • Skin cancer
    • Thrombosis
    • Urological cancer
    • Vaccines
    • Viral infections
    • Women’s Health
  • Strategy analysis
    • Bleeding disorders
    • Breast and gynecological cancer
    • Cardiovascular and Metabolic
    • Central Nervous System
    • Commercial Strategy
    • Dealmaking and R&D
    • Head and Neck Cancer
    • Hot Topics
    • Infectious Diseases
    • KOL Insight
    • Leukemia
    • Lung Cancer
    • Manufacturing
    • Market Access
    • Neurology
    • Oncology
    • Outsourcing
    • Pricing & Reimbursement
    • R&D
    • Regulatory & Therapeutic Area
    • Trends
    • Urological cancer
  • Company analysis
    • Big Pharma
    • Emerging Pharma
    • Hot Topics
    • Japan Pharma
    • M&A Analysis
    • Mid Pharma
  • Drug analysis
    • A
    • B-C
    • D-F
    • G-L
    • M-O
    • P-R
    • S-T
    • U-Z
  • MedTech analysis
    • Allergy
    • Autoimmune / Immunology
    • Cardiovascular
    • Dermatology
    • Endocrine
    • ENT / Dental
    • Gastroenterology
    • Hearing
    • Hematology
    • Infectious Diseases
    • Metabolic
    • Neurology
    • Obstetrics / Gynecology
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Osteoporosis
    • Psychiatry
    • Renal
    • Respiratory
    • Rheumatology
    • Urology
  • Opinion & analysis
    • Business Development
    • Business Management
    • Clinical Trials
    • Digital Health
    • Cybersecurity
    • Compliance & Risk
    • Digital patient management
    • Digital policy & regulation
    • Finance & Pricing
    • Healthcare Innovation
    • ICT and Health
    • Leadership
    • Legislation Regulation & Policy
    • Market Access
    • Market Intelligence
    • Medical
    • Pharmaceutical Device
    • Pharmaceutical Research
    • Strategy & Innovation
    • Tech companies & Data
    • Tech & Pharma
  • Blogs
  • Search
  • Menu
You are here: Home > Report library

Report library


  • Sort by Average rating
    • Default
    • Custom
    • Name
    • Price
    • Date
    • Popularity (sales)
    • Average rating
    • Relevance
    • Random
    • Product ID
  • Display 15 Products per page
    • 15 Products per page
    • 30 Products per page
    • 45 Products per page
  • U.S. Markets for Sports Medicine Products

    $4,750.00

    This dynamic new report from Medtech Insight includes analyses of products, current/forecast markets, competitors, and opportunities in the U.S. sports medicine devices market.

    September 22, 2016
    Find out more
  • U.S. Markets for Critical Care Patient Management Products

    $4,750.00

    This dynamic new report from Medtech Insight includes analyses of products, current/forecast markets, competitors, and opportunities in the U.S. market for critical care patient management products.

    September 22, 2016
    Find out more
  • U.S. Markets for Obesity Drugs & Devices

    $5,250.00

    U.S. Markets for Obesity Drugs & Devices

    September 22, 2016
    Find out more
  • U.S. Markets for Orthopedic Biologic and Tissue Engineered Products

    $4,750.00

    Tissue engineering, or regenerative medicine, represents a promising therapeutic possibility for the treatment of aggressive and deadly diseases.

    September 22, 2016
    Find out more
  • U.S. Neurostimulation Devices Market, June 2015

    $5,250.00

    An estimated 200 million people in the United States (U.S.) experience some degree of neurological impairment over the course of a lifetime.

    September 22, 2016
    Find out more
  • The Global Molecular Diagnostics Market

    $6,250.00

    The molecular diagnostic products market is the highest growth segment of the global in vitro diagnostics (IVDs) market valued at an estimated $5.3 billion in 2014 and projected to grow at a compound annual growth rate of 6.6% to $7.3 billion by the year 2019.

    September 22, 2016
    Find out more
  • U.S. Markets for Stroke Management

    $4,750.00

    The United States (U.S.) market for stroke management products, which encompasses diagnostic and therapeutic systems, is a market composed of old and new technologies that are often used together in order to prevent and treat stroke.  Improvements in stroke diagnostic systems will facilitate the delivery of timely stroke therapies within the optimum treatment window for patients suffering from stroke.

    September 22, 2016
    Find out more
  • Asia-Pacific: Surgical Procedure Volumes

    $5,250.00

    This report examines the healthcare trends in Asia-Pacific countries (Japan, China, South Korea, India, Thailand, Vietnam, Malaysia and Australia), as well as analyzes and forecasts (toward 2019).

    September 1, 2015
    Find out more
  • U.S. Markets for Advanced Wound Care Products

    $4,750.00

    U.S. Markets for Advanced Wound Care Products

    September 22, 2016
    Find out more
  • U.S. Markets for Drug and Fluid Delivery Devices

    $5,250.00

    Pharmacotherapy represents the first-line treatment in the management of most chronic and transient medical conditions warranting therapeutic intervention in the U.S.

    December 1, 2015
    Find out more
  • U.S. Patient Monitoring Devices Market, November 2015

    $5,250.00

    This report provides a summary of the nearly $2 billion U.S. patient monitoring devices market.

    November 2, 2015
    Find out more
  • Global Spinal Implants Market

    $5,250.00

    Spine disorders are a leading driver of healthcare costs worldwide, and range in severity from mild pain and loss of feeling to extreme pain and paralysis.  These disorders are primarily caused by degenerative conditions in the spine, deformity, tumors and trauma.

    December 1, 2015
    Find out more
  • Global Radiation Therapy Systems Market, March 2016

    $3,750.00

    This report covers the large, highly competitive, technology driven Global Market for Radiation Therapy Systems—valued at nearly $4.3 billion in 2015.

    March 1, 2016
    Find out more
  • Asia-Pacific Disease Incidence and Prevalence

    $5,250.00

    The Asia-Pacific (APAC) region is a part of the world which includes several developing and developed countries. Countries covered in this report include Australia, China, India, Japan, Malaysia, South Korea, Thailand, and Vietnam.

    January 1, 2016
    Find out more
  • U.S. Markets for Interventional Cardiology Products, April 2016

    $4,750.00

    In the United States (U.S.), approximately 85.6 million adults have at least one type of cardiovascular disease (CVD), a broad group of disorders that affect the heart and circulatory system. Cardiovascular disease in all its forms accounts for more deaths than any other major cause in the U.S.

    April 1, 2016
    Find out more
Page 85 of 86
Page 85 of 86«‹83848586›
  • Home
  • Terms and Conditions
  • Refund policy
  • Privacy Policy
  • Cookie Policy
  • Contact Us
  • About Us
  • Discounts
  • Market Spotlight – Reports
  • twitter
  • linkedin
  • Sitemap
Copyright © 2022 Pharma Intelligence UK Limited Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London, SW1P 1WG. Pharma Intelligence UK Limited is part of the Pharma Intelligence Group.

Sign up to the Pharma Intelligence Report Store Newsletter to get the latest blogs, news, reports and discounts!

Pharma Intelligence
This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Call Back
Scroll to top